In a report released on March 28, Gena Wang from Barclays maintained a Buy rating on Bluebird Bio (BLUE – Research Report), with a price target ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback